Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
- PMID: 38843331
- DOI: 10.1126/science.adk0775
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Abstract
How the KRAS oncogene drives cancer growth remains poorly understood. Therefore, we established a systemwide portrait of KRAS- and extracellular signal-regulated kinase (ERK)-dependent gene transcription in KRAS-mutant cancer to delineate the molecular mechanisms of growth and of inhibitor resistance. Unexpectedly, our KRAS-dependent gene signature diverges substantially from the frequently cited Hallmark KRAS signaling gene signature, is driven predominantly through the ERK mitogen-activated protein kinase (MAPK) cascade, and accurately reflects KRAS- and ERK-regulated gene transcription in KRAS-mutant cancer patients. Integration with our ERK-regulated phospho- and total proteome highlights ERK deregulation of the anaphase promoting complex/cyclosome (APC/C) and other components of the cell cycle machinery as key processes that drive pancreatic ductal adenocarcinoma (PDAC) growth. Our findings elucidate mechanistically the critical role of ERK in driving KRAS-mutant tumor growth and in resistance to KRAS-ERK MAPK targeted therapies.
Similar articles
-
Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.J Exp Clin Cancer Res. 2018 Jul 24;37(1):166. doi: 10.1186/s13046-018-0818-z. J Exp Clin Cancer Res. 2018. PMID: 30041673 Free PMC article.
-
Targeting the ERK mitogen-activated protein kinase cascade for the treatment of KRAS-mutant pancreatic cancer.Adv Cancer Res. 2022;153:101-130. doi: 10.1016/bs.acr.2021.07.008. Epub 2021 Sep 2. Adv Cancer Res. 2022. PMID: 35101228
-
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer.Science. 2024 Jun 7;384(6700):eadk0850. doi: 10.1126/science.adk0850. Epub 2024 Jun 7. Science. 2024. PMID: 38843329
-
Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives.Int J Mol Sci. 2024 Jan 28;25(3):1631. doi: 10.3390/ijms25031631. Int J Mol Sci. 2024. PMID: 38338909 Free PMC article. Review.
-
KRAS-related proteins in pancreatic cancer.Pharmacol Ther. 2016 Dec;168:29-42. doi: 10.1016/j.pharmthera.2016.09.003. Epub 2016 Sep 3. Pharmacol Ther. 2016. PMID: 27595930 Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous